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ABSTRACT
A total of 100 patients treated with a single session of microwave thermotherapy at 4 European 
centers was stratified according to 2 different types of obstruction (constrictive and compressive) and 
compared to clinical outcome at 6 months. Patients had a Madsen-Iversen score of 8 or more, 
maximum flow rate of 15 ml. per second or less and residual urine volume of 300 ml. or less at entry. 
The change in Madsen-Iversen score was the same in the 2 groups. Maximum flow rate increased 
from 8.71 ± 2.62 to 14,73 ± 4.04 ml. per second in the constrictive group, and from 8.54 ± 2.26 to 
10.41 ± 4.52 in the compressive group (p ^0.0001). Residual urine decreased from 96.00 ± 72.85 
to 40.34 ± 56.33 mL in the constrictive group and from 109.86 ± 67.09 to 84.65 ± 81.45 ml. in the 
compressive group (p ^0.0001). Success, as defined by an increase of 50% or more in maximum flow 
rate and Madsen-Iversen score, was noted in 68% of the constrictive but only 15% of the compressive 
groups (p ^¡0.0001 chi-square test for trend)* Selection by pressure-flow criteria for patients being 
considered for thermotherapy should improve the overall clinical results.
K ey W ords: pro s ta tic  hypertrophy , therm o th erapy , u ro  dynamics
Transurethral microwave thermotherapy is a minimally 
invasive treatment for benign prostatic obstruction.x*2 Ther­
apeutic levels of heating are achieved deep inside the pros­
tatic lateral lobes while preserving the urethral mucosa by 
application of 1,296 MHz* microwave radiation from a trans­
urethral antenna simultaneously cooled by circulating fluid 
within the applicator. It is presumed that clinical benefit is 
achieved by a small decrease in adenoma volume and the 
destruction of certain specific cell types that have some role 
in the development of bladder outflow obstruction. A signif­
icant decrease in benign prostatic hyperplasia (BPH) related 
symptoms, and an increase in maximum and average flow 
rates have been found in phase II studies worldwide.1“4 The 
clinical improvement has been shown not to be due to a 
placebo effect or to be the result of the associated urethral 
instrumentation in randomized trials of transurethral micro­
wave thermotherapy against sham therapy.5»6 However, the 
criteria currently used for inclusion do not prevent a high 
variability in terms of clinical response to microwave ther­
motherapy so that treatm ent outcome is difficult to forecast 
in the individual patient.
The heterogeneity of symptoms and objective parameters 
in patients with BPH is well known.7 Even more confusing is 
the differing patterns of obstruction as shown by pressure- 
flow studies.8«9 Invasive urodynamic studies have been used 
to investigate the pathophysiology of benign prostatic disease 
and to evaluate clinical outcome of various treatm ent modal­
ities but contradictory data exist as to the possibility of 
predicting the outcome of treatm ent by voiding urodynamic 
studies.10-12 Plotting the pressure and flow values obtained 
during voiding urodynamic studies produces a hysteresis 
curve that describes the unique urethral resistance relation­
ship of voiding for an individual.8 To simplify the complex 
hysteresis plot only the second part of the curve (from max­
imal flow to the end of micturition) is considered and de­
scribed by an approximated parabolic curve, which is known 
as the passive urethral resistance relation.9 To avoid the
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need for digital data processing the hysteresis plot can be 
approximated by a linear approach.13 The slope of the linear 
passive urethral resistance relation is calculated by the for­
mula (detrusor pressure at maximum flow -  minimum de­
trusor pressure during flow)/maximum flow rate. The various 
combinations of slope and minimum detrusor pressure dur­
ing flow provide the specific types of obstruction character­
izing difficulty in opening the urethra (compressive obstruc­
tion) and decreasing elasticity of the urethra (constrictive 
obstruction).9-14’15 Patients with symptomatic BPH always 
have both elements although one or the other will predomi­
nate. 16 In a previous series detrusor pressures required dur­
ing voiding were slightly decreased by transurethral micro­
wave thermotherapy but simple indicators of urethral 
resistance were decreased.17'18 More complex analysis of the 
passive urethral resistance shows that there is a decrease in 
slope but not of the “footpoint” (minimum detrusor pressure 
during flow) of the pressure-flow curve.19«20 No single simple 
parameter from the urodynamic study has been shown to 
predict the outcome of treatment. Preliminary analysis of our 
group suggested a correlation between urodynamic criteria 
at entry and clinical outcome of transurethral microwave 
thermo therapy.21 Therefore, a retrospective analysis was 
planned on 100 patients undergoing transurethral micro­
wave thermotherapy for BPH at 4 European centers to eval­
uate any predictive parameters that might identify the pa­
tients who respond best to microwave thermo therapy.
MATERIALS AND METHODS
Data from 100 patients treated at 4 European centers were 
collected. Each center submitted data from consecutive pa­
tients in whom a pressure-flow study was included in the 
pretreatment assessment and for whom complete followup 
data were available at 6 months. All patients were screened, 
treated and followed according to a common protocol. Inclu­
sion criteria consisted of candidates for transurethral resec­
tion of the prostate, patient age 45 years or older, bilobar
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prostatic hypertrophy, anesthesia risk group 1 to 3 according 
to the American Society of Anesthesiology, symptoms of pros­
tatism for more than 3 months, Madsen-Iversen score 
of 8 or more, peak flow rate of 15 ml. per second or less and 
residual urine volume of 300 mL or less. Patients were ex­
cluded if they had carcinoma of the prostate, bladder neo­
plasm, a neurological disorder tha t may affect bladder func­
tion, disorders of hemostasis, total hip replacements or other 
pelvic metallic implant, diabetic neuropathy, a cardiac pace­
maker, bladder stones, a history of prostatic surgery or rectal 
surgery other than hemorrhoidectomy, chronic renal failure 
due to BPH, urethral stricture, evidence of urinary tract 
infection or a prostate shorter than 35 mm. in longitudinal 
diameter. Baseline evaluation consisted of patient history, 
including Madsen-Iversen symptom score, physical examina­
tion, hematology and blood chemistry studies (including 
prostate specific antigen), urinalysis, urinary tract imaging, 
prostate ultrasonography, flexible cystoscopy, free average 
and peak flow rates (corrected for artifacts during a 2-second 
period), residual urine (measured by suprapubic sonography) 
and pressure-flow study. Urodynamic investigations were 
performed according to International Continence Society 
guidelines,22 although there were minor differences in equip­
ment and technique used at each site.
Treatment was done on an ambulatory basis without use of 
anesthesia. The operating software for this series of patients 
provided a 60-minute treatm ent with a maximum power 
output of 60 watts and a total possible power deposition of 
197 kj. The treatment has been described in more detail 
previously.17 In this series the CIO catheter (with the micro­
wave applicator located 10 mm. below the Foley balloon) was 
used in all patients. For the purposes of defining clinical 
outcome 6-month foliowup data were analyzed for changes in 
symptom score evaluation, uroflowmetry and residual urine.
Hard copies of the pressure-flow tracings were analyzed in 
a blind fashion by 2 separate investigators. A 1-second delay 
was used to calculate the detrusor pressure at various points 
of the flow curve.13 For each patient the parameters derived 
were minimum detrusor pressure during flow and detrusor 
pressure at maximum flow. Artifactual data in pressure and 
flow measurements were corrected when required (see fig­
ure). The 2 tracings from each individual patient were com­
pared and, in the absence of gross technical artifacts, the 
lowest detrusor pressure regimen was considered to be more 
representative of mechanical BPH obstruction (the obstruc­
tive condition). For each patient the linear passive urethral 
resistance relation was calculated.
The relative proportions of success and failure of micro­
wave thermotherapy were evaluated by percentage improve-
Pressure-flow tracing. Flow curve is shown at bottom and detrusor 
pressure is at top. Parameters derived are baseline detrusor pres­
sure 22 cm. water (a), detrusor opening pressure 90 cm. water (6), 
maximum detrusor pressure 128 cm. water (c), maximum flow rate 
and detrusor pressure at maximum flow 7.0 ml. per second and 120 
cm. water, respectively (c0, and detrusor pressure at end of flow 
65 cm. water (e). In this case minimum urethral opening pressure is 
found at end of flow (65 cm. water) and slope is calculated by formula 
previously reported, that is (120-65)/7.0 = 7.8.
ment in objective and subjective parameters. The number 
and percentages of patients improving by 75% or more, 50% 
or more, or 25% or less were analyzed.23 The hypothesis of 
significant differences between param eters before and after 
transurethral microwave thermo therapy in the total sample, 
as well as in the constrictive/compressive groups was tested 
by nonparametric means. Differences between baseline or 
posttreatment values in constrictive and compressive groups 
were evaluated by nonparametric tests. The relationship 
between subjective/objective parameters and clinical out­
come was evaluated by Spearman’s correlation coefficient. 
Significance of the increasing proportion of therapy success 
in the constrictive versus compressive groups was tested by 
the chi-square test for trend. Statistical analysis was done 
by computer.
RESULTS
The overall clinical results in terms of Madsen-Iversen 
symptom score, peak and average flow rates, voided volume 
and residual urine at 6 months are summarized in table 1. 
Analysis of symptoms by Madsen-Iversen symptom score 
showed a mean decrease of 61.8% after treatment. Peak and 
average flow rates increased by 35.0% and 28.3%, respec­
tively. Evaluation of the residual urine showed a mean de­
crease of 32.16%. All changes were highly statistically signif­
icant. No significant variation in voided volume occurred 
after treatm ent. Stratification of patients according to single 
subjective and objective parameters (peak and average flow 
rates, voided volume, residual urine, minimum urethral 
opening pressure, maximum flow rate during pressure-flow 
study and slope) did not show any strong correlation with 
clinical outcome using Spearman’s correlation coefficients.
Two groups of patients were identified by a 2-parameter 
discriminant factor (minimum urethral opening pressure 
and slope), defining predominantly constrictive (defined by a 
minimum urethral opening pressure of 45 cm. water or less 
and a slope of 2.5 or more) or compressive obstruction (de­
fined by a minimum urethral opening pressure value of 45 
cm. water or more and/or a slope value of less than  2.5), 
otherwise comparable before treatm ent but having a signif­
icantly different outcome (table 2). Madsen-Iversen score was 
similarly altered in each group, although there was a trend 
toward a slightly greater improvement in patients with con­
strictive obstruction. Significantly greater changes in peak 
and average flow rates were noted in the constrictive obstruc­
tion group. Voided volume remained unchanged for each 
group but residual urine was significantly less after trea t­
ment in the constrictive group.
Analysis of clinical outcome by highly selective criteria 
that include a percentage improvement in Madsen-Iversen 
symptom score and peak flow rate resulted in a large propor­
tion of successful cases in the constrictive group and in a 
significant percentage of failures in the compressive group 
(table 3). Stratification of patients treated at each of the 4 
sites for type of obstruction and outcome after transurethral 
microwave thermotherapy produces comparable results 
(data not shown), suggesting tha t the use of slightly different 
techniques and equipment for the pressure-flow study did 
not affect the reliability of the test.
DISCUSSION
The great variety of therapies currently available for symp­
tomatic BPH demands tha t the physician m ust make a choice 
for treatm ent in each individual patient. Previously, almost 
every patient with the combination of prostatic symptoms, 
demonstrable benign prostatic enlargement and low urinary 
flow rates could be treated by transurethral resection of the 
prostate with a high expectation of success. Sophisticated 
investigation for treatm ent selection was not required. How­
ever, the alternative treatm ents currently available do not
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T able 1. Parameters o f B PH  severity before and after microwave thermotherapy
No. Baseline* 6 Mos.* Difference* p Valuet
Madsen-Iversen score 100 14.18 ± 3.75 5.45 ± 4.85 -8.73 ± 0.55 ¿0.0001
Maximum flow rate (ml./sec.) 100 8.59 ± 2.36 11.6 ± 4.79 3.07 ± 0.45 ^0.0001
Av. flow rate (ml./sec.) 100 4.60 ± 1,47 5.90 ± 2.33 1.30 ± 0.26 ^0.0001
Voided vol. (ml.) 100 247.34 ± 95.27 252.55 ± 99.81 5.21 ± 11.4 ^0.6498
Residual urine (ml.) 100 105.84 ± 68.73 71.80 ± 77.43 -34.04 ± 8.88 SO.0002
* Mean plus or minus standard deviation, 
t  Wilcoxon matched-pairs signed rank test
T ab le 2. Sym ptom s and signs o f BPH  severity evaluated a t  
baseline and 6 months after microwave thermotherapy
Baseline 6 Mos. p Value45
Madsen-Iversen score:
Constrictive 14.41 ± 4.92 4.79 ± 4.32 =10.00001
Compressive 14.08 ± 3.44 5.71 ± 5.06 go.ooooi
p Valuet Not significant Not significant
Maximum flow rate:
Constrictive 8.71 ± 2.62 14.73 ± 4.04 go.ooooi
Compressive 8.54 ± 2.26 10.41 ± 4.52 g0 .0004
p Valuet Not significant ^0.00001
Av. flow rate:
Constrictive 4.72 ± 1.55 7.55 ± 2.15 £0.0001
Compressive 4.55 ± 1.44 5.21 ± 2.06 Not significant
p Valuet Not significant =S0.00001
Voided vol.:
Constrictive 244.38 ± 96.34 265.62 ± 102.75 Not significant
Compressive 248.55 ± 95.49 247.21 ± 98.83 Not significant
p Valuet Not significant Not significant
Post-void residual urine:
Constrictive 96.00 ± 72.85 40.34 ± 56.33 g0.0012
Compressive 109.86 ± 67.09 84.65 ± 81,45 ^0.0098
p Valuet Not significant =£0.0015
Patients are stratified according to the specific type of obstruction (mean 
values plus or minus standard deviation). 
i,: Wilcoxon matched-pairs signed rank test, 
t  Wilcoxon rank sum W test.
T able 3. Relative proportions of success and failure in constrictive
and compressive groups
No. Type of
Increase Obstruction (%) TotalNo.
Constrictive Compressive
Total No, pts. 29 71 100
% Increase in Madsen-Iversen
score and maximum flow rate:
75 or more 12 (41.38) 5 (7.04) 17
50 or more 19 (65.52) 11(15.49) 30
Less than 50 10 (34.48) 60 (84.50) 70
25 or less 5 (17.24) 50(70.42) 55
% Increase in maximum flow rate
(mL/sec.):
3 or more 25 (86.2) 6 (8,4) 31
Less than 3 4 (13.8) 65 (91,6) 69
Chi-square test for trend, p ^0.001, Categories are not mutually exclusive.
seem to have such high success rates and to make use of the 
undoubted advantages of less invasive therapies some crite­
ria for case selection are needed. In the past urodynamic 
studies in the elderly man have been used mainly to confirm 
the presence of obstruction, when the symptoms are atypical 
and for research purposes. Better understanding of the fluid 
mechanics associated with flow through collapsible tubes 
presently allows more sophisticated analysis of voiding dis­
orders, and may provide the answer to better patient selec­
tion and, consequently, the use of the most appropriate ther­
apy in each individual with symptomatic BPH.14
Clinical results from studies worldwide have been shown 
to be remarkably similar in terms of improvement in symp­
toms and flow rates. Symptoms are consistently reduced to 
levels (Madsen-Iversen symptom score of 5.5 in this series) 
close to those reported for a similarly aged noncomplaining 
population to be considered a success and to please the pa­
tient.24 However, the statistically significant increase in flow
rate of 30 to 40% and the inconclusive data with regard to the 
decrease in post-void residual volume do not satisfy the de­
sire of urologists for objective evidence of a successful out­
come. The overall clinical success of transurethral microwave 
thermo therapy, using selection criteria based on symptom 
score, peak flow rate and residual volume, has been sufficient 
to stimulate considerable interest but a significant propor­
tion of patients remains who do not respond well to treat­
ment. No single parameter of clinical assessment before 
treatment has been reported as a predictor of clinical out­
come in the individual.
We report a representative group of patients treated at 4 
European centers. The overall results are similar to previous 
data with a mean decrease in the Madsen-Iversen symptom 
score of 62% and an increase in peak flow rate of 36% to a 
value of 11.6 ml. per second, which cannot be explained by 
a simultaneous increase in voided volume. We have looked 
for possible ways to select the ideal patient for transurethral 
microwave thermotherapy by analysis of pretreatment pa­
rameters, including pressure-flow studies. The Madsen- 
Iversen symptom score, peak or average flow rate, voided 
volume and measurement of residual urine before transure­
thral microwave thermotherapy were of no use in selecting a 
group of patients with a better outcome than the group as 
a whole. Simple analysis of the urodynamic data by measure­
ment of the detrusor pressures developed at maximum flow 
rate or at minimal flow also could not be used to predict a 
better outcome.
Elasticity of the bladder neck and prostatic urethra, and 
the needed opening pressure are the 2 major factors that 
affect voiding in men with BPH. Two specific types of obstruc­
tion, according to the grade and type of urethral resistance 
(relative weight of urethral disorders), have been described 
by Schäfer.9 Compressive obstruction is characterized by dif­
ficulty in opening the urethra during voiding. After urinary 
flow is initiated a maximum rate can be reached with little 
pressure increase. Therefore, the pressure-flow study is char­
acterized by a high minimum urethral opening pressure 
value and low slope value of less than 2.5. Constrictive ob­
struction (the archetype being a urethral stricture) is char­
acterized by decreased elasticity at the level of the pro static 
urethra. Urinary flow can be induced with a low pressure but 
a significant increase in detrusor pressure is observed during 
the passage from minimal to maximal urinary flow rate. The 
pressure-flow study is, therefore, characterized by a fairly 
normal minimum urethral opening pressure value and a high 
slope of 2.5 or more. BPH patients are always characterized 
by the presence of both types of obstruction but in some the 
constrictive obstruction may be predominant.16
In our study patients were divided into 2 groups having 
either predominantly constrictive (29, or 29%) or compressive 
(71, or 71%) obstruction. It was impossible to distinguish 
between these 2 groups by the simple evaluation of symp­
toms, uroflowmetry or ultrasound assessment. After trans­
urethral microwave thermotherapy symptoms as graded by 
the Madsen-Iversen scoring system were equally improved in 
both groups. However, the results of treatment in both 
groups were significantly different in terms of the achieved 
urinary flow rates and decrease in residual urine. In the 
patients with predominantly constrictive obstruction the
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mean increase in peak flow rate was 69% as opposed to 22% 
for those with mainly compressive obstruction. The mean 
peak flow rate achieved was 14.7 ml. per second, which is not 
too dissimilar to many series on transurethral resection of 
the prostate.25 Similar changes were noted for the average 
flow rate with no difference in the voided volume, indicating 
an overall shorter flow time. Residual volume in the constric­
tive group was significantly more improved and decreased to 
a mean of 40 ml., which is also close to normal for men of this 
age.
Response rates to new treatments for symptomatic BPH 
have recently been proposed in an article by Holtgrewe out­
lining the regulatory affairs process for devices being submit­
ted to the Food and Drug Administration.23 Graded catego­
ries of response using greater than 75%, 50% and less than 
25% change in symptoms and/or flow rate have been sug­
gested. In this study the proportion of patients with a suc­
cessful outcome as defined by an improvement of more than 
75% in flow rate and symptom score is 41% for the constric­
tive group and only 7% for the compressive group. In the 
former group 65% of the patients had greater than a 50% 
response in both parameters. In terms of patients with a 
poor response, 70% with compressive obstruction had less 
than a 25% change in either or both categories. To facilitate 
comparison with success data in recent studies on BPH, 
patients with an increase in peak flow rate of 3 m l per second 
or more were evaluated.26*27 Of these patients 86% were from 
the constrictive group and 91% of those who failed to obtain 
an increase of this magnitude were from the compressive 
group. The division of patients into predominantly constric­
tive and compressive obstruction groups enables selection of 
those who will have a successful outcome.
It is important to note that the determination of the type of 
obstruction in an individual patient need not be particularly 
onerous or costly, nor need it be done with complex equip­
ment. There was no evidence of variability in the accuracy of 
the test among sites. In particular, it is of note that calcula­
tion of the minimum urethral opening pressure and the rel­
ative slope was based on differential pressure values (that is 
the numerator of the slope formula is given by detrusor 
pressure at maximum flow rate — minimum urethral open­
ing pressure). Differential pressure values are less depen­
dent on the technique used for recording the pressure-flow 
relationship than are absolute values. The investigation of 
voiding pressure studies may be considerably simplified to 
obtain the data used in our analysis, and additionally there is 
no need for a sophisticated computer analysis program to 
calculate the values of the linear passive urethral resistance 
relation for allocating patients to constrictive or compressive 
categories. In our experience this type of analysis may be 
done a t any urodynamic laboratory when pressure-flow trac­
ings are evaluated for report with no significant increase in 
urologist work load.
CONCLUSIONS
To date pressure-flow studies have been used as a research 
tool to investigate the effect of different treatment modalities 
on BPH. The results of our analysis support the decision of 
the American Urological Association to include a pressure- 
flow study in the evaluation process of any new treatment.23 
In the future, as different clinical syndromes are recog­
nized in patients with BPH, pressure-flow studies are 
likely to have a major role in decision making between 
therapeutic alternatives with different impacts on the dis­
ease. Our results strongly suggest th a t transurethral mi­
crowave thermotherapy should be offered to BPH patients 
with obstruction of the constrictive type, with transure­
thral resection of the prostate reserved for those with 
compressive bladder outflow obstruction. There have been 
suggestions in the literature that patients who do not fare
well after transure th ral resection of the prostate have the 
noncompressive type of obstruction.10 Although th is con­
cept remains to be tested fully, the in triguing prospect of 
using urodynamic studies to select patien ts for in situ  
heating and transu re th ra l resection of the prostate w ith 
improvement in the results of both trea tm en ts is raised.
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